A new wave of imaging technologies coupled with newly developed imaging probes are increasingly used in diagnostics, monitoring disease progression, interrogating cellular and molecular events, and assessing therapeutic efficacy in vivo. These novel technologies are largely based on optical modalities that offer an advantage of non-ionizing imaging at higher resolutions than most incumbent solutions. Used alone or coupled in novel ways with other imaging modalities, such as ultrasound, these solutions are slowly finding their way into clinical practice. Here, we look into the growing field of developers and analyze who is poised for success.
Contact us to learn the benefits of becoming a Lux member.
Or call us now
For North America (Boston Headquarters)
+1 (617) 502-5300
For EMEA (Amsterdam)
+31 20 280 7900
For APAC (Singapore)